Hypermethylation of the myogenic gene Myf-3 in human breast carcinomas

Anticancer Research

Volumn 16, Issue 4 A, 1996, Pages 2111-2115

  Hähnel, Roland ^a   Harvey, Jennet ^a   Kay, Peter ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Breast carcinoma; Differentiation; Gene; Hypermethylation; Myf 3; Myogenic

Indexed keywords

MYOGENIC FACTOR;

ARTICLE; BREAST CARCINOMA; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; BASE SEQUENCE; BREAST; BREAST NEOPLASMS; DNA, NEOPLASM; FEMALE; HUMANS; LYMPHATIC METASTASIS; METHYLATION; MYOD PROTEIN; NEOPLASM INVASIVENESS; PLOIDIES; POLYMORPHISM, GENETIC; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REFERENCE VALUES; RESTRICTION MAPPING; S PHASE; TRANS-ACTIVATORS;

EID: 0029759694     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Davies RL, Weintraub H, Lassar AB: Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51: 987-1000, 1987.
2. Braun T, Bober E, Buschhausen-Denker G, Kotz S, Grzeschik K, Arnold HH: Differential expression of myogenic determination genes in muscle cells: possible autoactivation by the myf gene products. EMBO J 8: 3617-3625, 1989.
3. Jones PA, Wolkowicz MJ, Rideout WM, Gonzales FA, Marziasz GA, Coetzee GA, Tapscott SJ: De novo methylation of the Myo-D1 CpG island during the establishment of immortal cell lines. Proc Natl Acad Sci USA 87: 6117-6121, 1990.
4. Baylin SB, Makos M, Wu J, Yen RWC, de Bustros A, Vertino P, Nelkin BD: Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression. Cancer Cells 3: 383-90, 1991.
5. Spruck CH, Rideout WM, Jones P: DNA methylation and cancer. In: DNA methylation: molecular biology and biological significance. (Eds) Jost JP, Saluz HB, Birkhauser Verlag, Basel, 1993.
6. Kay PH, Jacobsen PF, Taylor J, Spagnolo DV: The significance of DNA methylation in cancer. Adv Anat Path 2: 353-361, 1995.
7. Kay PH, Taylor J, Kees UR, Baker DL and Spagnolo DV: Myf-3 hypermethylation in malignant lymphoproliferative disorders. Int J Cancer 62: 797-799, 1995.
8. Rideout WM, Eversole-Cine P, Spruck CH, Hustad CM, Coetzee GA, Gonzales FA, Jones PA: Progressive increases in the methylation status and heterochromatinisation of the MyoD CpG island during oncogenic transformation. Mol Cell Biol 14: 6143-52, 1994.
9. Hähnel R, Avenell, MHJ, Hähnel E. Estrogen and progesterone receptor assays by the EIA method (Abbott) of low speed supernates of breast cancer homogenates. Clin Chem 35: 2226-2227, 1989.
10. Sakamoto G: Infiltrating carcinoma: major histological types. In: Diagnostic Histopathology of the Breast. (Eds) Page DL. Anderson TJ. Churchill Livingstone, pp. 193-235, 1987.
11. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long term follow-up. Histopathology 19: 403-410, 1991.
12. Harvey JM, Sterrett GF, Berryman IL, Hopley JH: Nuclear DNA content of human breast carcinoma: a comparison of results obtained by microspectrophotometry and flow cytometry of paraffin embedded tissue. Pathology 25: 261 -267, 1993.
13. Maniatis I, Fritsch EF, Sambrook J: Molecular cloning. A laboratory manual. Cold Spring Harbor, New York, 1982.
14. Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 95: 503-509, (1975)
15. Bird AP: CpG islands as gene markers in the vertebrate nucleus. Trends in Genetics 3: 342-347, 1987.
16. de Bustros A, Nelkin BD,. Silverman A. Ehrlich, G. Poiesz B. Baylin SB: The short arm of chromosome 11 is a "hot spot" for hypermethylation in human neoplasia. Proc Natl Acad Sci USA 85: 5693-5697,1988.
17. Makos M, Nelkin BD, Lerman MI, Latif F, Zbar B, Baylin SB: Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc Natl Acad Sci USA 89: 1929-1933, (1992).
18. Ohtani-Fujita N, Fujita T, Aoike A, Osifchin NE, Robbins PD, Sakai T: CpG methylation inactivates the promoter activity of the human retinoblastoma tumor suppressor gene. Oncogene 8: 1063-1067, 1993.
19. Ottaviano YL, Issa JP, Parl FF, Smith HS, Baylin SB, Davidson NE: Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res 54: 2552-2555, 1994.
20. Ferguson AT, Lapidus RG, Baylin SB, Davidson NE: Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. Cancer Res 55: 2279-2283, 1995.